About Dr. Wang Xin
Dr. Wang Xin (汪昕) is one of China's most distinguished neurologists and the Director of the Department of Neurology at Ruijin Hospital, affiliated with Shanghai Jiao Tong University School of Medicine. He holds the title of Chief Physician and Professor and is nationally recognized as a leading authority on epilepsy, autoimmune neurology, and cerebrovascular disease.
Over a career spanning more than three decades, Dr. Wang has built Ruijin Hospital's Neurology Department into one of the premier neurological centers in eastern China. He is particularly renowned for his expertise in drug-resistant epilepsy, autoimmune encephalitis, and neuromyelitis optica spectrum disorder (NMOSD) — complex neurological conditions where accurate diagnosis and specialized treatment can be life-changing. His contributions have shaped national clinical guidelines and influenced neurology practice across China.
International patients with epilepsy, autoimmune neurological conditions, stroke, or other complex neurological disorders consistently identify Dr. Wang as one of Shanghai's top neurologists for both primary treatment and expert second opinions.
Professional Positions and Affiliations
- Director, Department of Neurology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
- Chairman, Epilepsy Committee, Chinese Society of Neurology
- Vice Chairman, Autoimmune Neurology Committee, Chinese Society of Neurology
- Editorial Board Member: Epilepsia, Journal of Neurology, Chinese Journal of Neurology
- Member, International League Against Epilepsy (ILAE)
- Member, European Academy of Neurology (EAN)
Specialties and Clinical Expertise
- Epilepsy — comprehensive epilepsy evaluation including video-EEG monitoring, high-density EEG, MEG, and advanced MRI (3T epilepsy protocol); anti-seizure medication optimization; surgical evaluation for drug-resistant epilepsy (stereo-EEG, intracranial monitoring); neuromodulation (VNS, DBS, RNS)
- Autoimmune Encephalitis — anti-NMDAR, anti-LGI1, anti-CASPR2, anti-GABA-B, and other antibody-mediated encephalitides; immunotherapy (IVIG, steroids, rituximab, cyclophosphamide) and tumor search
- Neuromyelitis Optica Spectrum Disorder (NMOSD) — AQP4-IgG and MOG-IgG testing; acute attack treatment and long-term relapse prevention (eculizumab, inebilizumab, satralizumab, rituximab)
- Multiple Sclerosis — disease-modifying therapy selection and monitoring; MRI surveillance and relapse management
- Stroke and Cerebrovascular Disease — acute stroke management (thrombolysis, thrombectomy), secondary prevention, and post-stroke rehabilitation coordination
- Neurodegenerative Diseases — Parkinson's disease, Alzheimer's disease, and frontotemporal dementia; multidisciplinary management
- Peripheral Neuropathy — CIDP, GBS, vasculitic neuropathy, and hereditary neuropathies; nerve conduction studies and EMG
- Headache and Migraine — CGRP inhibitor therapy, Botox, and neuromodulation for chronic migraine
Academic and Research Contributions
Dr. Wang Xin has published over 200 peer-reviewed papers in leading international neurology journals, with a particular focus on the epidemiology and genetics of epilepsy in Chinese patients, the clinical spectrum of autoimmune encephalitis in China, and the optimization of immunotherapy for NMOSD. His landmark research on the prevalence and clinical features of anti-NMDAR encephalitis in Chinese patients — one of the largest series in Asia — has been widely cited and has contributed to international understanding of this condition.
He chairs the Epilepsy Committee of the Chinese Society of Neurology and has been the lead author on China's national epilepsy management guidelines. He is a regular invited speaker at the International Epilepsy Congress (IEC), the European Congress of Epileptology (ECE), and the European Academy of Neurology (EAN) annual congress.
Hospital: Ruijin Hospital Neurology Department
Under Dr. Wang's leadership, Ruijin Hospital's Neurology Department operates:
- A dedicated Epilepsy Monitoring Unit (EMU) with long-term video-EEG capability
- A Stroke Unit with 24/7 thrombolysis and thrombectomy capability
- An Autoimmune Neurology Clinic for encephalitis, NMOSD, and MS
- A Neuroimmunology Laboratory with comprehensive antibody testing capability
- A Multidisciplinary Epilepsy Surgery Program with neurosurgery, neuroimaging, and neuropsychology
Why International Patients Choose Dr. Wang Xin
- China's leading epileptologist — Chairman of China's national epilepsy committee and ILAE member
- Autoimmune encephalitis expertise — one of China's largest clinical series and deepest diagnostic experience
- Access to novel NMOSD therapies — eculizumab, inebilizumab, and satralizumab
- Comprehensive epilepsy surgery program — stereo-EEG, intracranial monitoring, and neuromodulation
- EAN member — aligned with European neurology standards
- English-language support available through CMCS concierge coordination
Practical Information for International Patients
- Hospital: Ruijin Hospital, 197 Ruijin Er Road, Huangpu District, Shanghai
- Appointment Lead Time: 2″4 weeks for new patients; urgent neurological cases expedited through CMCS
- Languages: Mandarin Chinese; English interpretation provided by CMCS
- Pre-consultation: Overseas EEG, MRI, and antibody test results can be reviewed remotely through CMCS
How CMCS Can Help
China Medical Concierge Shanghai (CMCS) provides end-to-end support for international patients seeking neurological care with Dr. Wang Xin at Ruijin Hospital. Our services include priority appointment booking, medical record and EEG/MRI report translation, remote pre-consultation review, on-site interpretation, accommodation coordination, insurance liaison, and post-treatment follow-up with your home country neurologist.
📧 Contact us: contract@medicalsh.com
🌐 medicalsh.com
0 commentaire